Search Results

Deals

Advent International and Warburg Pincus Complete Acquisition of Baxter’s BioPharma Solutions Business

Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, announced the completion of their previously announced acquisition of Baxter International Inc.’s BioPharma Solutions business.

October 2, 2023

·

4 min read

Pharm Country

Advent Therapeutics Awarded $3 Million NIH Grant for Novel Neonatal Lung Therapy

Advent Therapeutics, Inc. has been awarded a $3 million National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase IIB grant.

July 18, 2023

·

8 min read

Genetown

ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints

Boston Scientific Corporation announced positive 12-month results from the pivotal ADVENT clinical trial of the FARAPULSE™ Pulsed Field Ablation System*, a nonthermal treatment in which electric fields selectively ablate heart tissue in patients with atrial fibrillation.

August 27, 2023

·

6 min read

FDA

Advent Therapeutics Receives FDA Rare Pediatric Disease Designation for Retinol Palmitate for Prevention of Bronchopulmonary Dysplasia in Premature Infants

Advent Therapeutics, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) Rare Pediatric Disease Designation (RPDD) for its vitamin A metabolic and reparative respiratory drugs for the prevention of Bronchopulmonary Dysplasia (BPD) in premature infants.

July 20, 2023

·

3 min read

BioMidwest

Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion

Baxter International Inc., a leading global medtech company, announced that it has signed a definitive agreement to divest its BioPharma Solutions business to Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.

May 8, 2023

·

9 min read

BioCapital

Northwest Biotherapeutics and Advent BioServices Announce Receipt of License for Commercial Manufacturing at Sawston, U.K. Facility

Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”) and Advent BioServices jointly announce that a MIA license has been approved and issued by the Medicines and Healthcare Products Regulatory Agency (MHRA) for commercial manufacturing of cell therapy products at the GMP facility in Sawston, U.K.

March 20, 2023

·

5 min read

Press Releases

Meet Gaelic Laboratories, your trusted testing and manufacturing partner

11 July 2024: Gaelic Laboratories unveils its new website today, launching an upgraded and expanded laboratory technology base for advanced analytical testing, and a newly re-fitted Beta-Lactam manufacturing facility, using the latest state-of-the art technology.

July 11, 2024

·

2 min read

Deals

US BioTek Laboratories Expands Diagnostic Testing Portfolio with Acquisition of RealTime Laboratories

US BioTek Laboratories (“US BioTek”), a Clinical Laboratory Improvement Amendments (CLIA) and CAP accredited laboratory, announces the acquisition of Dallas, TX-based RealTime Laboratories (“RealTime”), a pioneer in the field of mycotoxin testing.

March 19, 2024

·

2 min read

Policy

Association for Diagnostics & Laboratory Medicine (formerly AACC) survey finds that FDA’s final laboratory developed tests rule will impede the fight against the U.S.'s drug epidemic

The Association for Diagnostics & Laboratory Medicine released the results of a survey that ADLM conducted to determine how the Food and Drug Administration’s final laboratory developed tests rule will impact patient access to essential tests.

June 25, 2024

·

4 min read

Press Releases

Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.

Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).

July 1, 2024

·

5 min read